Conversely, immensely popular compounds like BPC-157 possess zero rigorous human data to justify their widespread adoption
Measuring biomarkers like fasting insulin, C-peptide, and inflammatory markers (hsCRP) can provide context for whether your metabolic profile aligns with conditions where prescription GLP-1 therapy has the strongest clinical evidence
Las sociedades mdicas cientficas alertan sobre el riesgo del uso indiscriminado de anlogos de GLP-1 (Semaglutida y/o Liraglutida) por profesionales sin la formacin adecuada, y la automedicacin, poniendo en peligro la salud pblica
Longitudinal studies have reported slower rates of cognitive decline and improved quality of life among individuals adhering to IF protocols compared with those following unrestricted eating patterns [79]
Semaglutide, while transformative in its ability to regulate blood glucose and promote weight loss, can induce gastrointestinal side effects such as nausea, vomiting, and diarrhea
Hey both